(Q56428272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Primary biliary cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

primary biliary cholangitis

30 January 2020

main subject

0 references

author

Carlo Selmi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Ross L. Coppel

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

3

M Eric Gershwin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Christopher L Bowlus

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

28 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

9777

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

1600-1609

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

Pediatric-onset primary biliary cirrhosis

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

The serology of the Addison-Gull syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Epidemiology and natural history of primary biliary cirrhosis in a US community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Characterization of antimitochondrial antibodies in health adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Primary biliary cirrhosis: an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Primary biliary cirrhosis once rare, now common in the United Kingdom?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Is autoimmunity a matter of sex?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Bacteriuria and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Bacteria and primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Does a betaretrovirus infection trigger primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Natural history of early primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Detection of anti-branched chain 2-oxo acid dehydrogenase complex (BCOADC)-E2 antibody in primary biliary cirrhosis by ELISA using recombinant fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Antinuclear antibodies giving the 'multiple nuclear dots' or the 'rim-like/membranous' patterns: diagnostic accuracy for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

The consequences of apoptosis in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

The X and why of xenobiotics in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Apotopes and the biliary specificity of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

The true impact of fatigue in primary biliary cirrhosis: a population study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

The specificity of fatigue in primary biliary cirrhosis: evaluation of a large clinic practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Patients with primary biliary cirrhosis do not show post-exercise depression of cortical excitability.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Globus pallidus magnetization transfer ratio, T(1) and T(2) in primary biliary cirrhosis: relationship with disease stage and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: results of a 9 year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Endogenous opioid peptides and chronic liver disease: from bedside to bench.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Pruritus in primary biliary cirrhosis: pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Lysophosphatidic acid is a potential mediator of cholestatic pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

AGA technical review on osteoporosis in hepatic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Clustering and commonalities among autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Antinuclear antibodies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Accuracy of staging in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Transplantation trends in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Prognosis in primary biliary cirrhosis: model for decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Time course of histological progression in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Glucocorticosteroids for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

A follow-up study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Liver transplantation for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

The optimal timing of liver transplantation in patients with chronic cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961965-4

7 January 2021

10.1016/S0140-6736(10)61965-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21529926%20AND%20SRC:MED&resulttype=core&format=json

release_7nk4kxqryngy3pi3tzh25fv7sm

30 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7nk4kxqryngy3pi3tzh25fv7sm

24 November 2022

mapped directly with Wikidata item

1 reference